Beijing Geriatric Hospital
11
4
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Chinese Familial Alzheimer's Network
Role: collaborator
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
Role: collaborator
China Cognition and Aging Study
Role: collaborator
Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)
Role: collaborator
Clinical Trial of Biolimus-coated Intracranial Balloon Dilation Catheter
Role: collaborator
Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases
Role: collaborator
Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection
Role: collaborator
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
Role: collaborator
COPD Co-infection With Tuberculosis on Th17 Cell Differentiation
Role: collaborator
Non-contact DCS-Speckle Multi-parameter Imaging for Neurological Diseases
Role: collaborator
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Role: collaborator
All 11 trials loaded